Topiroxostat

Topiroxostat is a pharmaceutical drug used primarily in the treatment of gout. It is a xanthine oxidase inhibitor, a type of medication that works by decreasing the amount of uric acid produced in the body. Topiroxostat is marketed under the brand name Topiloric in Japan by Sanwa Kagaku Kenkyusho.

Mechanism of Action

Topiroxostat inhibits the enzyme xanthine oxidase, which is involved in the production of uric acid in the body. By inhibiting this enzyme, topiroxostat reduces the levels of uric acid, thereby preventing the formation of uric acid crystals that cause gout.

Uses

Topiroxostat is used in the treatment of chronic gout, a type of inflammatory arthritis caused by high levels of uric acid in the blood. It is also used to treat hyperuricemia, a condition characterized by an excess of uric acid in the blood.

Side Effects

Common side effects of topiroxostat include liver function abnormalities, kidney function abnormalities, and gastrointestinal disorders. Rare but serious side effects include severe skin reactions and hypersensitivity reactions.

Contraindications

Topiroxostat is contraindicated in patients with severe renal impairment or end-stage renal disease. It is also contraindicated in patients with a history of hypersensitivity to topiroxostat or any of its components.

Interactions

Topiroxostat may interact with other medications, including other xanthine oxidase inhibitors, diuretics, and certain types of cancer medications. Patients should inform their healthcare provider of all medications they are currently taking before starting treatment with topiroxostat.

See Also

• Gout
• Xanthine oxidase inhibitor
• Uric acid
• Hyperuricemia

This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia